iTeos Therapeutics
ITOS
#7707
Rank
S$0.36 B
Marketcap
$9.87
Share price
-2.02%
Change (1 day)
-31.66%
Change (1 year)

Revenue for iTeos Therapeutics (ITOS)

Revenue in 2024 (TTM): S$47.47 Million

According to iTeos Therapeutics's latest financial reports the company's current revenue (TTM ) is S$47.51 Million. In 2023 the company made a revenue of S$16.63 Million a decrease over the revenue in the year 2022 that were of S$0.35 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for iTeos Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) S$47.47 M185.42%
2023 S$16.63 M-95.36%
2022 S$0.35 B-23.02%
2021 S$0.46 B
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA